StabilityStudies.in
Comprehensive Stability Study Protocol for Polymorphic Drugs
This protocol outlines the procedures for conducting stability studies on polymorphic drugs, focusing on polymorph stability, dissolution, and potential transformation under different conditions.
Parameter | Details |
---|---|
Product Name | [Polymorphic Drug Name] |
Batch Number | [Batch Number] |
Objective | To assess the stability of polymorphic drugs under specified environmental conditions. |
Test Parameters |
– Polymorph Stability – Dissolution – Degradation Products |
Storage Conditions | [e.g., 25°C/60% RH, 40°C/75% RH] |
Test Intervals | [Specify intervals: 0, 3, 6 months, etc.] |
Acceptance Criteria | No significant change in polymorph stability or dissolution rate. |
Regulatory Guidelines | ICH Q1A(R2), FDA, EMA |
Signatories | QA, QC, Regulatory Affairs |
StabilityStudies.in